Navigation Links
MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
Date:8/23/2007

children in the analysis had BPD.

For full prescribing information for Synagis, see the company's website at: http://www.medimmune.com/products/synagis/index.asp.

About International RSV Prophylaxis

Outside the United States, Synagis is distributed by Illinois-based Abbott, a global, broad-based health care company. Abbott also has the ex-U.S. distribution rights to motavizumab.

About MedImmune, Inc.

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. With approximately 3,000 employees worldwide and headquarters in Maryland, MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN). For more information, visit MedImmune's website at http://www.medimmune.com.


'/>"/>
SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
4. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
8. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
9. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
10. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
11. Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... February 27, 2015 ... Überwachungssystem für kongestive Herzinsuffizienz (CHF) in seiner ...     Die ... neuartiges Herzüberwachungssystem für Patienten mit kongestiver Herzinsuffizienz ... sie ein Finanzierungsvorhaben über 5 Mio. USD ...
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015 ... DESI are increasing in applications as their ... research firm Kalorama Information.  Kalorama Information says ... MS) is the most powerful tool in ... (mass spec; MS) through its traditional techniques ...
(Date:2/26/2015)... Feb. 26, 2015  AbbVie (NYSE: ... studies in its neuroscience and oncology development programs ... th American Academy of Neurology annual meeting ... April 18-25. The accepted abstracts feature results from ... to investigational treatments in AbbVie,s pipeline. Presentations will ...
Breaking Medicine Technology:Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7
... VEGAS, Jan. 9, 2012 BASIS Science, Inc. ( www.mybasis.com ... and health tracker, the Basis™ B1 band, will be demoing ... showing its web-based personal dashboard for the first time. The ... people information about their everyday health and wellness. ...
... the nation,s largest independent specialty pharmacy in the ... rights from Regeneron for its new drug EYLEA™ ... 2011, EYLEA (aflibercept) Injection was approved by the ... the treatment of neovascular (wet) age-related macular degeneration ...
Cached Medicine Technology:BASIS Science to Demo Basis Band at 2012 International CES; Reveals Design of Web Dashboard 2Diplomat Specialty Pharmacy to Provide Specialty Pharmacy Services for EYLEA™ (aflibercept) Injection 2
(Date:2/27/2015)... February 27, 2015 Clinovo, a leading ... validated Electronic Data Capture (EDC) at the CALBIO2015 ... March 2nd and March 3rd at Booth # 141. ... and DIY CRF and edit-check builder allowing Clinical Trials ... matter of days, without any programming experience. Clinovo’s new ...
(Date:2/27/2015)... honor of American Heart Month in February, Dr. Edwin Scott, from ... on how to improve heart health. , Heart disease may be ... to accept it as their fate. Although one may lack the ... sex or age — there are some key heart disease prevention ... to improve heart health and prevent heart disease: , 1. Don't ...
(Date:2/27/2015)... New York, NY (PRWEB) February 27, 2015 ... lawsuits ( http://www.lipitorlawsuitcenter.com/ ) that allege use of the ... Type 2 diabetes has issued a new order pertaining ... two bellwether trials, Bernstein Liebhard LLP comments. The Order, ... of South Carolina, on February 25th, directs the parties ...
(Date:2/27/2015)... On February 24 2015, Harper’s Bazaar Magazine posted ... that details the development of RT001, a form of topical ... FDA trials. For those afraid of needles, the idea of ... course, if the drug ultimately gets FDA approval it will ... goo.gl/PQvQwk) , “As the article notes, the size of the ...
(Date:2/27/2015)... The winter season is here, and with it ... grows, it can be harmful to the home and to ... of mold growth with the help of Enviro-Test. Enviro-Test, the ... the best ways to prevent mold during the winter months. ... for mold to thrive. Mold must be removed properly, otherwise ...
Breaking Medicine News(10 mins):Health News:Clinovo to Demo Its Self-Service, Cloud-Based EDC Solution at CALBIO2015 on March 2nd and 3rd, 2015 2Health News:Center for Primary Care Celebrates American Heart Month 2Health News:Center for Primary Care Celebrates American Heart Month 3Health News:Center for Primary Care Celebrates American Heart Month 4Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:Is Topical Botox the Next Big Thing? 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2
... HUNTINGTON BEACH, Calif., Oct. 19 Impact,Medical ... medical technology,company, announced today that it has ... New York to profile the Company in ... The report is now available,at http://www.watervilleresearch.com/companies/medical/244-1.html ...
... York City to Meet Breslin, ... Need During the Holidays, BETHEL, Conn., Oct. 19 ... for Duracell Holiday,Ambassadors to help "Power A Smile" this holiday ... her Academy Award,nominated role in "Little Miss Sunshine," to spread ...
... Oct. 19 Rapid Pathogen Screening Inc.,(RPS) ... Vice President of Corporate,Relations. In this role, ... and implementing the Group Purchasing Organizations and ... held a similar,position in Celleration Inc.,s Corporate ...
... BEACH, Fla., Oct. 19 Allergan (AGN) has,entered into ... in specialty training for aesthetic medicine and surgery. According,to ... insuring that the right,type of training is provided to ... "this type of long term agreement is a milestone ...
... General Dr. Joycelyn Elders, Dr. Harold Freeman, Lovell A. Jones, PhD, and Wilmington Mayor ... ... The National Conference on African Americans and Cancer ... national cancer care and prevention forum convenes primary ...
... The SCOOTER,Store ( http://www.thescooterstore.com/aboutus/ ) ... Award from Runzheimer International for the ... cited for an outstanding program of,managing ... helped make,the nation,s largest supplier of ...
Cached Medicine News:Health News:Waterville Investment Research Profiles Impact Medical Solutions 2Health News:Waterville Investment Research Profiles Impact Medical Solutions 3Health News:Duracell and Actress Abigail Breslin Search for Holiday Ambassadors 2Health News:Duracell and Actress Abigail Breslin Search for Holiday Ambassadors 3Health News:Rapid Pathogen Screening Announces New Vice President of Corporate Relations 2Health News:National Conference Aims to Eliminate Disparities in Cancer Treatment and Deaths for African Americans 2Health News:National Conference Aims to Eliminate Disparities in Cancer Treatment and Deaths for African Americans 3Health News:The Scooter Store Wins Second Consecutive 'Best Practices' Award From Runzheimer International 2
... etched into the gel tray which casts a ... cables, three 7x10 cm gel trays, 4 aluminum ... The Chameleon can accomodate up to five combs ... of 120 samples with a 2.5 cm path ...
... of a Separation-Control unit for system control ... gel staining. The optional PhastTransfer Kit quickly ... unit. Electrophoresis is performed on a thermostatic ... 0 to +70 C. Multi-step programming capability ...
... 2000 apparatus and ready-to-use gels are the ... of nucleic acids by submerged gel electrophoresis. ... system, offering full compatibility and optimal performance, ... SEA 2000 and a unique staining tray, ...
... 2000 apparatus and ready-to-use gels are the ... of nucleic acids by submerged gel electrophoresis. ... system, offering full compatibility and optimal performance, ... SEA 2000 and a unique staining tray, ...
Medicine Products: